Fighting Sickle Cell
New Sickle Cell Therapies Will Be Out of Reach Where They Are Needed Most. There is no clear path for African patients like Nkem to get access to the treatments, which have multimillion-dollar price tags and are highly complex to manufacture and deliver.
Read here.